Christopher Warren to Cover Medical Devices
ARLINGTON, Va., Nov. 2 /PRNewswire-FirstCall/ -- FBR Capital Markets Corporation (Nasdaq: FBCM) (FBR Capital Markets) today announced that Christopher Warren has joined FBR Capital Markets as a Senior Vice President and Senior Research Analyst within its healthcare group and will focus on the medical device sector.
"Chris has nearly ten years of experience in equity research, and we value the disciplined, rigorous method he's developed as an analyst over that period," said David Khani, Director of Research. "We continue to expand our team of analysts, and the addition of coverage for medical device equities will complement the expertise of our healthcare group. FBR Capital Markets Research has been investing in its growth and value products and continues to expand these platforms."
Before joining FBR Capital Markets, Mr. Warren was a senior medical device analyst with SunTrust Robinson Humphrey. Prior to that, he was a senior medical device analyst with Janney Montgomery Scott. Mr. Warren began his career as an investment banking analyst at Credit Suisse First Boston.
Mr. Warren will be based in FBR Capital Markets' New York Office.
FBR Capital Markets Corporation (FBR Capital Markets), a majority-owned
subsidiary of Friedman, Billings, Ramsey Group, Inc. (FBR), provides
investment banking*, merger and acquisition advisory services*,
institutional brokerage*, asset management and private wealth services. FBR
Capital Markets focuses capital and financial expertise on eight industry
sectors: consumer, diversified industrials, energy & natural resources,
financial institutions, healthcare, insurance, real estate, and technology,
media
'/>"/>
| SOURCE FBR Capital Markets Corporation Copyright©2007 PR Newswire. All rights reserved |